| Perwaiz Kahn, MD, | |
|
150 Pine Forest Dr Ste 204, Conroe, TX 77384-5303 | |
| (936) 271-2222 | |
| (936) 271-2221 |
| Full Name | Perwaiz Kahn |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 150 Pine Forest Dr Ste 204, Conroe, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043291388 | NPI | - | NPPES |
| M2987 | Other | TEXAS MEDICAL BOARD LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | M2987 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Home Health Of Houston | Houston, TX | Home health agency |
| Hca Houston Healthcare Conroe | Conroe, TX | Hospital |
| Aspire Behavioral Health Of Conroe, Llc | Conroe, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Zak Medical Group Pa | 3173847225 | 2 |
| Hospital Docs Pa | 7517052822 | 28 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced the launch of software upgrades for Audit Tracker Online. The upgrades to MRO's request management program offer hospitals and health systems enhanced performance and functionality in effectively managing payer audits and denials from initial medical records request through appeals and payment resolution.
The Los Angeles Times reports that the health care proposals being considered by Congress would prohibit insurers from charging higher premiums based on preexisting conditions, "[b]ut the far reaching clampdown on insurers leaves one highly controversial element untouched: the issue of charging higher premiums to older policyholders than to younger, presumably healthier consumers who are less likely to file costly claims.
More than 400 of the nation's most respected health care leaders today issued a joint Open Letter to Congress declaring that the health care system is in crisis and is unsustainable and calling on Congress to act now on meaningful reforms. They state that Congress has a moral and ethical obligation to improve healthcare for all our citizens now.
It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
› Verified 4 days ago
| Entity Name | Hospital Docs Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871792309 PECOS PAC ID: 7517052822 Enrollment ID: O20071002000420 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced the launch of software upgrades for Audit Tracker Online. The upgrades to MRO's request management program offer hospitals and health systems enhanced performance and functionality in effectively managing payer audits and denials from initial medical records request through appeals and payment resolution.
The Los Angeles Times reports that the health care proposals being considered by Congress would prohibit insurers from charging higher premiums based on preexisting conditions, "[b]ut the far reaching clampdown on insurers leaves one highly controversial element untouched: the issue of charging higher premiums to older policyholders than to younger, presumably healthier consumers who are less likely to file costly claims.
More than 400 of the nation's most respected health care leaders today issued a joint Open Letter to Congress declaring that the health care system is in crisis and is unsustainable and calling on Congress to act now on meaningful reforms. They state that Congress has a moral and ethical obligation to improve healthcare for all our citizens now.
It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
› Verified 4 days ago
| Entity Name | Zak Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427464833 PECOS PAC ID: 3173847225 Enrollment ID: O20150120000218 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced the launch of software upgrades for Audit Tracker Online. The upgrades to MRO's request management program offer hospitals and health systems enhanced performance and functionality in effectively managing payer audits and denials from initial medical records request through appeals and payment resolution.
The Los Angeles Times reports that the health care proposals being considered by Congress would prohibit insurers from charging higher premiums based on preexisting conditions, "[b]ut the far reaching clampdown on insurers leaves one highly controversial element untouched: the issue of charging higher premiums to older policyholders than to younger, presumably healthier consumers who are less likely to file costly claims.
More than 400 of the nation's most respected health care leaders today issued a joint Open Letter to Congress declaring that the health care system is in crisis and is unsustainable and calling on Congress to act now on meaningful reforms. They state that Congress has a moral and ethical obligation to improve healthcare for all our citizens now.
It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Perwaiz Kahn, MD, 150 Pine Forest Dr Ste 204, Conroe, TX 77384-5303 Ph: (936) 271-2222 | Perwaiz Kahn, MD, 150 Pine Forest Dr Ste 204, Conroe, TX 77384-5303 Ph: (936) 271-2222 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced the launch of software upgrades for Audit Tracker Online. The upgrades to MRO's request management program offer hospitals and health systems enhanced performance and functionality in effectively managing payer audits and denials from initial medical records request through appeals and payment resolution.
The Los Angeles Times reports that the health care proposals being considered by Congress would prohibit insurers from charging higher premiums based on preexisting conditions, "[b]ut the far reaching clampdown on insurers leaves one highly controversial element untouched: the issue of charging higher premiums to older policyholders than to younger, presumably healthier consumers who are less likely to file costly claims.
More than 400 of the nation's most respected health care leaders today issued a joint Open Letter to Congress declaring that the health care system is in crisis and is unsustainable and calling on Congress to act now on meaningful reforms. They state that Congress has a moral and ethical obligation to improve healthcare for all our citizens now.
It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
› Verified 4 days ago
Hussein Nooruddin Yamani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Blvd, Suite 200, Conroe, TX 77304 Phone: 936-441-9680 Fax: 936-539-9685 | |
James Dwayne Pickett, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 508 Medical Center Blvd, Ste 200, Conroe, TX 77304 Phone: 936-760-4600 Fax: 936-760-4601 | |
Mr. John A Startz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Medical Center Blvd, Ste 104, Conroe, TX 77304 Phone: 936-756-2888 Fax: 936-756-2892 | |
Candace Lynn Walkley, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1169 Grand Central Pkwy Bldg E, Conroe, TX 77304 Phone: 936-525-3600 | |
Amit Mori, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd Ste 235, Conroe, TX 77304 Phone: 281-698-7070 Fax: 480-685-9922 | |
Darshan Vipin Tolat, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 River Pointe Dr, Ste 100, Conroe, TX 77304 Phone: 936-756-2555 Fax: 936-756-2534 |